This is the first gene editor to use a CRISPR-associated transposase to make targeted edits at therapeutically useful levels in humans.

The global antibody and protein labeling kits market is projected to grow significantly over the next decade, increasing from approximately USD 685 million in 2024 to over USD 1.56 billion by 2034, ...